Haydo Baba

HEALTH OF WOMAN. 2019.3(139): 8–14; doi 10.15574/HW.2019.139.8

Голяновский А. В. , Иванкова И. М. , Слободян Ю. В.
Национальная медицинская академия последипломного образования имени П.Л. Шупика, г. Киев

В статье представлены данные последних рандомизированных исследований и опубликованных в 2018 году двух руководств Королевского колледжа акушеров-гинекологов Великобритании по эпидемиологии, факторам риска, современным методам диагностики, алгоритмам родоразрешения и инновационным хирургическим методам лечения при предлежании и приращении плаценты (pl. рraevia/accreta). С точки зрения доказательной медицины освещена актуальность проблемы в аспекте антенатальной диагностики патологии плацентации для прогнозирования и профилактики жизнеугрожающих геморрагических осложнений. Приведены данные, свидетельствующие о необходимости мультидисциплинарного подхода к родоразрешению беременных в случае установления диагноза placenta percreta с проведением донного кесарева сечения и гистерэктомии без попытки отделения плаценты.

Предоставленные последние данные будут полезны для практикующих акушеров-гинекологов с целью оптимального ведения и родоразрешения беременных с этой тяжелой акушерской патологией.

Ключевые слова: предлежание плаценты, аномально инвазивная плацента, приращение плаценты, placenta accretа, placenta praevia, placenta increta/ percreta.

СПИСОК ЛИТЕРАТУРЫ

1. Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Michael A. 2018. Belfort for the FIGO. Placenta Accreta Diagnosis and Management: Expert Consensus Panel. Int J Obstet Gynecol. 140; 3:281-290. https://doi.org/10.1002/ijgo.12409

2. ERM Jauniaux, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline 27a); RCOG: 27/09/2018. https://www.rcog.org.uk/en/guidelines-researchservices/guidelines/gtg27a/.

3. Irving FC, Hertig AT. 1937. A study of placenta accreta. Surg Gynec Obstet. 64: 178– 200.

4. Clausen, C, Lonn, L, Langhoff-Roos J. 2014. Management of placenta percreta: A review of published cases. Acta Obstet Gynecol Scand. 93: 138– 143. https://doi.org/10.1111/aogs.12295

5. Amsalem, H, Kingdom, JC, Farine, D et al. 2011. Planned caesarean hysterectomy versus “conserving” caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 33: 1005– 1010. https://doi.org/10.1016/S1701-2163(16)35049-6

6. Jauniaux E, Collins, SL, Jurkovic, D, Burton, GJ. 2016. Accreta placentation: A systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 215: 712– 721. https://doi.org/10.1016/j.ajog.2016.07.044

7. Jauniaux E, Bidhe A. 2017. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after caesarean delivery: A systematic review and meta-analysis. Am J Obstet Gynecol. 217: 27–36. https://doi.org/10.1016/j.ajog.2017.02.050

8. Esakoff TF, Handler SJ, Granados JM, Caughey AB. 2012. PAMUS: Placenta accreta management across the United States. J Matern Fetal Neonatal Med. 25: 761– 765. https://doi.org/10.3109/14767058.2011.598585

9. Jolley JA, Nageotte MP, Wing DA, Shrivastava, V. 2012. Management of placenta accreta: A survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med. 25: 756– 760. https://doi.org/10.3109/14767058.2011.594467

10. Wright JD, Silver RM, Bonanno C et al. 2013. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med. 26: 1602– 1609. https://doi.org/10.3109/14767058.2013.793662

11. Walker MG, Allen L, Windrim RC et al. 2013. Multidisciplinary management of invasive placenta previa. J Obstet Gynaecol Can. 35: 417– 425. https://doi.org/10.1016/S1701-2163(15)30932-4

12. Grace Tan, Jobling SE, Wallace TW, McNeilage EM, Manolitsas LJ, Hodges RJ. 2013. Surgical management of placenta accreta: A 10-year experience. Acta Obstet Gynecol Scand. 92: 445– 450. https://doi.org/10.1111/aogs.12075

13. Shamshirsaz AA, Fox KA, Salmanian B et al. 2015. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 212: 218.e1– 218.e9. https://doi.org/10.1016/j.ajog.2014.08.019

14. Eller AG, Porter TF, Soisson P, Silve RM. 2009. Optimal management strategies for placenta accreta. BJOG. 116: 648– 654. https://doi.org/10.1111/j.1471-0528.2008.02037.x

15. Warshak CR, Ramos GA, Eskander R et al. 2010. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 115: 65– 69. https://doi.org/10.1097/AOG.0b013e3181c4f12a

16. Wright, JD, Pri-Paz, S, Herzog, TJ, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol. 2011; 205: 38.e1– 38.e6. https://doi.org/10.1016/j.ajog.2011.01.040

17. Al-Khan A, Gupta V, Illsley NP et al. 2014. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci. 21:761. https://doi.org/10.1177/1933719113512528

18. Seoud MA, Nasr R, Berjawi GA et al. 2017. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. J Neonatal Perinatal Med. 10: 9– 15. https://doi.org/10.3233/NPM-1622

19. Eller AG, Bennett MA, Sharshiner M et al. 2011. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol.  117: 331– 337. https://doi.org/10.1097/AOG.0b013e3182051db2

20. Camuzcuoglu A, Vural M, Hilali NG et al. 2016. Surgical management of 58 patients with placenta praevia percreta. Wien Klin Wochenschr. 128: 360– 366. https://doi.org/10.1007/s00508-016-0962-4

21. Norris BL, Everaert W, Posma E et al. 2016. The urologist’s role in multidisciplinary management of placenta percreta. BJU Int. 117: 961– 965. https://doi.org/10.1111/bju.13332

22. Wright JD, Herzog TJ, Shah M et al. 2010. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol. 115: 194– 200. https://doi.org/10.1097/AOG.0b013e3181df94e8

23. Brookfield KF, Goodnough LT, Lyell DJ, Butwick AJ. 2014. Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion. 54: 1530– 1536. https://doi.org/10.1111/trf.12483

24. Woldu SL, Ordone MA, Devin PC, Wright JD. 2014. Urologic considerations of placenta accreta: A contemporary tertiary care institutional experience. Urol Int. 93: 74– 79. https://doi.org/10.1159/000356064

25. Smulian JC, Pascual AL, Hesham H et al. 2017. Invasive placental disease: The impact of a multi-disciplinary team approach to management. J Matern Fetal Neonatal Med. 30: 1423– 1427. https://doi.org/10.1080/14767058.2016.1216099

26. Silver RM, Fox KA, Barton JR et al. 2015. Center of excellence for placenta accreta. Am J Obstet Gynecol. 212: 561– 568. https://doi.org/10.1016/j.ajog.2014.11.018

27. Brennan DJ, Schulze B, Chetty N et al. 2015. Surgical management of abnormally invasive placenta: A retrospective cohort study demonstrating the benefits of a standardized operative approach. Acta Obstet Gynecol Scand. 94: 1380– 1386. https://doi.org/10.1111/aogs.12768

28. Green L, Knigh M, Seeney F et al. 2016. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: A population based study. Br J Haematol. 172: 616– 624. https://doi.org/10.1111/bjh.13864

29. Shamshirsaz AA, Fox KA, Erfani H et al. 2017. Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time. Am J Obstet Gynecol. 216: 612.e1– 612.e5. https://doi.org/10.1016/j.ajog.2017.02.016

30. Bowman ZS, Manuck TA, Eller AG, Simon M, Silver RM. 2014. Risk factors for unscheduled delivery in patients with placenta accreta. Am J Obstet Gynecol. 210: 241.e1– 241.e6. https://doi.org/10.1016/j.ajog.2013.09.044

31. Rac MW, Wells CE, Twickler DM, Moschos E, McIntire DD, Dashe JS. 2015. Placenta accreta and vaginal bleeding according to gestational age at delivery. Obstet Gynecol. 125: 808– 813. https://doi.org/10.1097/AOG.0000000000000674

32. Robinson BK, Grobman WA. 2010. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 116: 835– 842. https://doi.org/10.1097/AOG.0b013e3181f3588d

33. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. 2017. FER-ASAP Investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: An international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 45: 443– 453. https://doi.org/10.1515/jpm-2016-0050

34. Wong L, Smith S, Gilstrop M et al. 2016. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 91: 590– 593. https://doi.org/10.1002/ajh.24361

35. Tam Tam KB, Dozier J, Martin JN. 2012. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: A systematic review. J Matern Fetal Neonatal Med. 25: 329– 334. https://doi.org/10.3109/14767058.2011.576720

36. Abbas F, Talati J, Wasti S, Akra S, Ghaffar S, Qureshi R. 2000. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol. 164: 1270– 1274. https://doi.org/10.1016/S0022-5347(05)67153-4

37. Matsubara S, Kuwata T, Usui R et al. 2013. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand. 92: 372– 377. https://doi.org/10.1111/aogs.12074

38. Belfort MA, Shamshirsaz AA, Fox KA. 2017. A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy. Am J Obstet Gynecol. 217: 222.e1– 222.e3. https://doi.org/10.1016/j.ajog.2017.05.001

39. Ioscovich A, Shatalin D, Butwick AJ, Ginosar Y, Orbach-Zinger S, Weiniger CF. 2016. Israeli survey of anesthesia practice related to placenta previa and accreta. Acta Anaesthesiol Scand. 60: 457– 464. https://doi.org/10.1111/aas.12656

40. Iwata A, Murayama Y, Itakura A, Baba K, Seki H, Takeda S. 2010. Limitations of internal iliac artery ligation for the reduction of intraoperative hemorrhage during cesarean hysterectomy in cases of placenta previa accreta. J Obstet Gynaecol Res. 36: 254– 259. https://doi.org/10.1111/j.1447-0756.2009.01157.x

41. Lilker, SJ, Meyer, RA, Downey, KN, Macarthur, AJ. Anesthetic considerations for placenta accreta. Int J Obstet Anesth. 2011; 20: 288– 292. https://doi.org/10.1016/j.ijoa.2011.06.001

42. Taylor NJ, Russell R. 2017. Anaesthesia for abnormally invasive placenta: A single-institution case series. Int J Obstet Anesth. 30: 10– 15. https://doi.org/10.1016/j.ijoa.2017.01.008

43. Munoz LA, Mendoza GJ, Gomez M, Reyes LE, Arevalo JJ. 2015. Anesthetic management of placenta accreta in a low-resource setting: A case series. Int J Obstet Anesth. 24: 329– 334. https://doi.org/10.1016/j.ijoa.2015.05.005

44. Kocaoglu N, Gunusen I, Karaman S, Ergenoglu AM, Firat V. 2012. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: A retrospective study. Ginekol Pol. 83: 99– 103.

45. Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. 2016. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: A retrospective cohort study of 50 consecutive cases. Can J Anaesth. 63: 1233– 1244. https://doi.org/10.1007/s12630-016-0695-x

46. Hong JY, Jee YS, Yoon HJ, Kim SM. 2003. Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: Maternal hemodynamics, blood loss and neonatal outcome. Int J Obstet Anesth. 12: 12– 16. https://doi.org/10.1016/S0959-289X(02)00183-8

47. Butwick AJ, Carvalho B, El-Sayed YY. 2014. Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth. 113: 661– 668. https://doi.org/10.1093/bja/aeu150

48. Walker MG, Pollard L, Talati C et al. 2016. Obstetric and anaesthesia checklists for the management of morbidly adherent placenta. J Obstet Gynaecol Can. 38: 1015– 1023. https://doi.org/10.1016/j.jogc.2016.08.015

49. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 389: 2105– 2116. 2017.

50. Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V. 2016. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 95: 28– 37. https://doi.org/10.1111/aogs.12798

51. Lakshmi SD, Abraham R. 2016. Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: A randomized controlled study. J Clin Diagn Res. 10: 17– 21. https://doi.org/10.7860/JCDR/2016/21702.9050

52. Ray I, Bhattacharya R, Chakraborty S, Bagchi C, Mukhopadhyay S. 2017. Role of Intravenous tranexamic acid on caesarean blood loss: A Prospective randomised study. J Obstet Gynaecol India.  66: 347– 352. https://doi.org/10.1007/s13224-016-0915-x

53. Maged AM, Helal OM, Elsherbin MM et al. 2015. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. Int J Gynecol Obstet. 131: 265– 268. https://doi.org/10.1016/j.ijgo.2015.05.027

54. Chou MM, Kung HF, Hwang JI, Chen WC, Tseng JJ. 2015. Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation. Taiwan J Obstet Gynecol. 54: 493– 498. https://doi.org/10.1016/j.tjog.2014.03.013

55. Luo F, Xie L, Xie P, Liu S, Zhu Y. 2017. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: A retrospective study. Taiwan J Obstet Gynecol. 56: 147– 152. https://doi.org/10.1016/j.tjog.2016.11.004

56. Takahashi H, Ohkuchi A, Usui R, Suzuki H, Baba Y, Matsubara S. 2016. Factors contributing to massive blood loss on peripartum hysterectomy for abnormally invasive placenta: Who bleeds more? Obstet Gynecol Int. 2016: 5349063. https://doi.org/10.1155/2016/5349063

57. Teixidor Vinas M, Chandraharan E, Moneta MV, Belli AM. 2014. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. Clin Radiol. 69: e345– e351. https://doi.org/10.1016/j.crad.2014.04.005

58. Ballas J, Hull AD, Saenz C et al. 2012. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: A management paradox. Am J Obstet Gynecol. 207: 216.e1– 216.e5. https://doi.org/10.1016/j.ajog.2012.06.007

59. Cali G, Forlani F, Giambanco L et al. 2014. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 179: 36– 41. https://doi.org/10.1016/j.ejogrb.2014.05.007

60. Carnevale FC, Kondo MM, Oliveira Sousa W et al. 2011. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol. 34: 758– 764. https://doi.org/10.1007/s00270-011-0166-2

61. D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura JR. 2015. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can Assoc Radiol. 66: 179– 184. https://doi.org/10.1016/j.carj.2014.08.002

62. Duan XH, Wang YL, Han XW et al. 2015. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol. 70: 932– 937. https://doi.org/10.1016/j.crad.2015.03.008

63. Kidney DD, Nguye AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. 2001. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. Am J Roentgenol.  176: 1521– 1524. https://doi.org/10.2214/ajr.176.6.1761521

64. Dubois J, Garel L, Grignon A, Lema M, Leduc L. 1997. Placenta percreta: Balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol. 176: 723– 726. https://doi.org/10.1016/S0002-9378(97)70582-9

65. Minas V, Gul N, Shaw E, Mwenenchanya S. 2015. Prophylactic balloon occlusion of the common iliac arteries for the management of suspected placenta accreta/percreta: Conclusions from a short case series. Arch Gynecol Obstet. 291: 461– 465. https://doi.org/10.1007/s00404-014-3436-9

66. Mok M, Heidemann B, Dundas K, Gillespie I, Clark V. 2008. Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth. 17: 255– 261. https://doi.org/10.1016/j.ijoa.2007.11.010

67. Panici PB, Anceschi M, Borgia ML et al. 2012. Intraoperative aorta balloon occlusion: Fertility preservation in patients with placenta previa accreta/increta. J Matern Fetal Neonatal Med. 25: 2512– 2516. https://doi.org/10.3109/14767058.2012.712566

68. Shih JC, Liu KL, Shyu MK. 2005. Temporary balloon occlusion of the common iliac artery: New approach to bleeding control during cesarean hysterectomy for placenta percreta. Am J Obstet Gynecol. 193: 1756– 1758. https://doi.org/10.1016/j.ajog.2005.08.033

69. Sivan E, Spira M, Achiron R et al. 2010. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: Can it prevent cesarean hysterectomy? Am J Perinatol. 27: 455– 461. https://doi.org/10.1055/s-0030-1247599

70. Tan CH, Tay KH, Sheah K et al. 2007. erioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. Am J Roentgenol. 189: 1158– 1163. https://doi.org/10.2214/AJR.07.2417

71. Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. 2015. Precesarean prophylactic balloon catheters for suspected placenta accreta: A randomized controlled trial. Obstet Gynecol.  126: 1022– 1028. https://doi.org/10.1097/AOG.0000000000001113

72. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W. 2006. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol.  29: 354– 361. https://doi.org/10.1007/s00270-005-0023-2

73. Shrivastava V, Nageotte M, Majo C, Haydo M, Wing D. 2007. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol. 197: 402.e1– 402.e5. https://doi.org/10.1016/j.ajog.2007.08.001

74. Levine AB, Kuhlman K, Bonn J. 1999. Placenta accreta: Comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med. 8: 173– 176. https://doi.org/10.1002/(SICI)1520-6661(199907/08)8:4<173::AID-MFM7>3.3.CO;2-M

75. Clausen C, Stensballe J, Albrechtse CK, Hanse MA, Lonn L, Langhoff-Roos J. 2013. Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta. Acta Obstet Gynecol Scan. 92: 386– 391. https://doi.org/10.1111/j.1600-0412.2012.01451.x

76. Sentilhes L, Goffinet F, Kayem G. 2013. Management of placenta accreta. Acta Obstet Gynecol Scand. 92: 1125– 1134. https://doi.org/10.1111/aogs.12222

77. Greenberg JI, Suliman A, Iranpou P, Angle N. 2007. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: A cautionary case. Am J Obstet Gynecol. 197: 470.e1– 470.e4. https://doi.org/10.1016/j.ajog.2007.05.017

78. Sewell MF, Rosenblum D, Ehrenberg H. 2006. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol. 108: 746– 748. https://doi.org/10.1097/01.AOG.0000201992.80130.2c

79. Teare J, Evans E, Belli A, Wendler R. 2014. Sciatic nerve ischaemia after iliac artery occlusion balloon catheter placement for placenta percreta. Int J Obstet Anesth. 23: 178– 181. https://doi.org/10.1016/j.ijoa.2013.11.002

80. Chouliaras S, Hickling DJ, Tuck JS. 2009. Thromboembolism of the leg following prophylactic balloon occlusion of the uterine arteries. BJOG. 116: 1278– 1279. https://doi.org/10.1111/j.1471-0528.2009.02217.x

81. Gagnon J, Boucher L, Kaufman I, Brown R, Moore A. 2013. Iliac artery rupture related to balloon insertion for placenta accreta causing maternal hemorrhage and neonatal compromise. Can J Anaesth. 60: 1212– 1217. https://doi.org/10.1007/s12630-013-0038-0

82. Bishop S, Butler K, Monaghan S, Chan K, Murphy G, Edozie L. 2011. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 20: 70– 73. https://doi.org/10.1016/j.ijoa.2010.09.012

83. Matsueda S, Hidaka N, Kondo Y, Fujiwara A, Fukushima K, Kato K. 2015. External iliac artery thrombosis after common iliac artery balloon occlusion during cesarean hysterectomy for placenta accreta in cervico-isthmic pregnancy. J Obstet Gynaecol Res. 41: 1826– 1830. https://doi.org/10.1111/jog.12777

84. Dilauro MD, Dason S, Athreya S. 2012. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: Literature review and analysis. Clin Radiol. 67: 515– 520. https://doi.org/10.1016/j.crad.2011.10.031

85. Neb H, Zacharowski K, Meybohm P. 2017. Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol. 30: 294– 299. https://doi.org/10.1097/ACO.0000000000000463

86. McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ. 2010. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care. 38: 492– 499. https://doi.org/10.1177/0310057X1003800313

87. Elagamy A, Abdelaziz A, Ellaithy M. 2013. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth. 22: 289– 293. https://doi.org/10.1016/j.ijoa.2013.05.007

88. Lew E, Tagore S. 2015. Implementation of an obstetric cell salvage service in a tertiary women’s hospital. Singapore Med J. 56: 445– 449. https://doi.org/10.11622/smedj.2015121

89. Albright CM, Rouse DJ, Werner EF. 2014. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol. 124: 690– 696. https://doi.org/10.1097/AOG.0000000000000465

90. Esper SA, Waters JH. 2011. Intra-operative cell salvage: A fresh look at the indications and contraindications. Blood Transfus. 9: 139– 147.

91. Weiniger CF, Kabiri D, Ginosar Y, Ezra Y, Shachar B, Lyell DJ. 2016. Suspected placenta accreta and cesarean hysterectomy: Observational cohort utilizing an intraoperative decision strategy. Eur J Obstet Gynecol Reprod Biol. 198: 56– 61. https://doi.org/10.1016/j.ejogrb.2015.12.020

92. Belfort MA, Shamshiraz AA, Fox K. 2017. Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. Am J Obstet Gynecol. 216: 78.e1– 78.e2. https://doi.org/10.1016/j.ajog.2016.10.030

93. Rossetti D, Vitale SG, Bogani G, Rapisarda AM, Gulino FA, Frigerio L. 2015. Usefulness of vessel-sealing devices for peripartum hysterectomy: A retrospective cohort study. Updates Surg. 67: 301– 304. https://doi.org/10.1007/s13304-015-0289-0

94. Arendas K, Lortie KJ, Singh SS. 2012. Delayed laparoscopic management of placenta increta. J Obstet Gynaecol Can. 34: 186– 189. https://doi.org/10.1016/S1701-2163(16)35162-3

95. Smith DD, Perez-Delboy A, Burke WM, Tergas AI. 2016. Buttock necrosis after uterine artery embolization for delayed hysterectomy in placenta percreta. Case Rep Obstet Gynecol. 2016: 6921280. https://doi.org/10.1155/2016/6921280

96. Rupley DM, Tergas AI, Palmerola KL, Burke WM. 2016. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecol Oncol Rep. 17: 53– 55. https://doi.org/10.1016/j.gore.2016.05.009

97. Skinner BD, Golichowski AM, Raff GJ. 2012. Laparoscopic-assisted vaginal hysterectomy in a patient with placenta percreta. JSLS. 16: 143– 147. https://doi.org/10.4293/108680812X13291597717022

Коллектив из трёх гитаристов, основан в 1991 году Полом Ричардсом из Солт-Лейк-Сити, штат Юта, Бертом Ламсом из Бельгии и Хайдо Мория из Токио.
Они встретились в 1987 году на семинаре Guitar Craft (Роберта Фриппа), а чуть позже, в Лос-Анджелесе они основали трио «California Guitar». В настоящее время группа использует нестандартный строй гитары. Выступления группы содержат оригинальные композиции и каверы на рок-хиты и на классические произведения. Их стиль включает в себя традиции европейской классической музыки, рока, блюза и джаза.

"Картинки с выставки" Модеста Петровича

"Щедрык" Леонтовича

"Цилиндрические колокола" Майка Олдфилда

"Дорз" и тд

HEALTH OF WOMAN. 2019.3(139): 8–14; doi 10.15574/HW.2019.139.8

Голяновский А. В. , Иванкова И. М. , Слободян Ю. В.
Национальная медицинская академия последипломного образования имени П.Л. Шупика, г. Киев

В статье представлены данные последних рандомизированных исследований и опубликованных в 2018 году двух руководств Королевского колледжа акушеров-гинекологов Великобритании по эпидемиологии, факторам риска, современным методам диагностики, алгоритмам родоразрешения и инновационным хирургическим методам лечения при предлежании и приращении плаценты (pl. рraevia/accreta). С точки зрения доказательной медицины освещена актуальность проблемы в аспекте антенатальной диагностики патологии плацентации для прогнозирования и профилактики жизнеугрожающих геморрагических осложнений. Приведены данные, свидетельствующие о необходимости мультидисциплинарного подхода к родоразрешению беременных в случае установления диагноза placenta percreta с проведением донного кесарева сечения и гистерэктомии без попытки отделения плаценты.

Предоставленные последние данные будут полезны для практикующих акушеров-гинекологов с целью оптимального ведения и родоразрешения беременных с этой тяжелой акушерской патологией.

Ключевые слова: предлежание плаценты, аномально инвазивная плацента, приращение плаценты, placenta accretа, placenta praevia, placenta increta/ percreta.

СПИСОК ЛИТЕРАТУРЫ

1. Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Michael A. 2018. Belfort for the FIGO. Placenta Accreta Diagnosis and Management: Expert Consensus Panel. Int J Obstet Gynecol. 140; 3:281-290. https://doi.org/10.1002/ijgo.12409

2. ERM Jauniaux, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline 27a); RCOG: 27/09/2018. https://www.rcog.org.uk/en/guidelines-researchservices/guidelines/gtg27a/.

3. Irving FC, Hertig AT. 1937. A study of placenta accreta. Surg Gynec Obstet. 64: 178– 200.

4. Clausen, C, Lonn, L, Langhoff-Roos J. 2014. Management of placenta percreta: A review of published cases. Acta Obstet Gynecol Scand. 93: 138– 143. https://doi.org/10.1111/aogs.12295

5. Amsalem, H, Kingdom, JC, Farine, D et al. 2011. Planned caesarean hysterectomy versus “conserving” caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 33: 1005– 1010. https://doi.org/10.1016/S1701-2163(16)35049-6

6. Jauniaux E, Collins, SL, Jurkovic, D, Burton, GJ. 2016. Accreta placentation: A systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 215: 712– 721. https://doi.org/10.1016/j.ajog.2016.07.044

7. Jauniaux E, Bidhe A. 2017. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after caesarean delivery: A systematic review and meta-analysis. Am J Obstet Gynecol. 217: 27–36. https://doi.org/10.1016/j.ajog.2017.02.050

8. Esakoff TF, Handler SJ, Granados JM, Caughey AB. 2012. PAMUS: Placenta accreta management across the United States. J Matern Fetal Neonatal Med. 25: 761– 765. https://doi.org/10.3109/14767058.2011.598585

9. Jolley JA, Nageotte MP, Wing DA, Shrivastava, V. 2012. Management of placenta accreta: A survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med. 25: 756– 760. https://doi.org/10.3109/14767058.2011.594467

10. Wright JD, Silver RM, Bonanno C et al. 2013. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med. 26: 1602– 1609. https://doi.org/10.3109/14767058.2013.793662

11. Walker MG, Allen L, Windrim RC et al. 2013. Multidisciplinary management of invasive placenta previa. J Obstet Gynaecol Can. 35: 417– 425. https://doi.org/10.1016/S1701-2163(15)30932-4

12. Grace Tan, Jobling SE, Wallace TW, McNeilage EM, Manolitsas LJ, Hodges RJ. 2013. Surgical management of placenta accreta: A 10-year experience. Acta Obstet Gynecol Scand. 92: 445– 450. https://doi.org/10.1111/aogs.12075

13. Shamshirsaz AA, Fox KA, Salmanian B et al. 2015. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 212: 218.e1– 218.e9. https://doi.org/10.1016/j.ajog.2014.08.019

14. Eller AG, Porter TF, Soisson P, Silve RM. 2009. Optimal management strategies for placenta accreta. BJOG. 116: 648– 654. https://doi.org/10.1111/j.1471-0528.2008.02037.x

15. Warshak CR, Ramos GA, Eskander R et al. 2010. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 115: 65– 69. https://doi.org/10.1097/AOG.0b013e3181c4f12a

16. Wright, JD, Pri-Paz, S, Herzog, TJ, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol. 2011; 205: 38.e1– 38.e6. https://doi.org/10.1016/j.ajog.2011.01.040

17. Al-Khan A, Gupta V, Illsley NP et al. 2014. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci. 21:761. https://doi.org/10.1177/1933719113512528

18. Seoud MA, Nasr R, Berjawi GA et al. 2017. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. J Neonatal Perinatal Med. 10: 9– 15. https://doi.org/10.3233/NPM-1622

19. Eller AG, Bennett MA, Sharshiner M et al. 2011. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol.  117: 331– 337. https://doi.org/10.1097/AOG.0b013e3182051db2

20. Camuzcuoglu A, Vural M, Hilali NG et al. 2016. Surgical management of 58 patients with placenta praevia percreta. Wien Klin Wochenschr. 128: 360– 366. https://doi.org/10.1007/s00508-016-0962-4

21. Norris BL, Everaert W, Posma E et al. 2016. The urologist’s role in multidisciplinary management of placenta percreta. BJU Int. 117: 961– 965. https://doi.org/10.1111/bju.13332

22. Wright JD, Herzog TJ, Shah M et al. 2010. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol. 115: 194– 200. https://doi.org/10.1097/AOG.0b013e3181df94e8

23. Brookfield KF, Goodnough LT, Lyell DJ, Butwick AJ. 2014. Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion. 54: 1530– 1536. https://doi.org/10.1111/trf.12483

24. Woldu SL, Ordone MA, Devin PC, Wright JD. 2014. Urologic considerations of placenta accreta: A contemporary tertiary care institutional experience. Urol Int. 93: 74– 79. https://doi.org/10.1159/000356064

25. Smulian JC, Pascual AL, Hesham H et al. 2017. Invasive placental disease: The impact of a multi-disciplinary team approach to management. J Matern Fetal Neonatal Med. 30: 1423– 1427. https://doi.org/10.1080/14767058.2016.1216099

26. Silver RM, Fox KA, Barton JR et al. 2015. Center of excellence for placenta accreta. Am J Obstet Gynecol. 212: 561– 568. https://doi.org/10.1016/j.ajog.2014.11.018

27. Brennan DJ, Schulze B, Chetty N et al. 2015. Surgical management of abnormally invasive placenta: A retrospective cohort study demonstrating the benefits of a standardized operative approach. Acta Obstet Gynecol Scand. 94: 1380– 1386. https://doi.org/10.1111/aogs.12768

28. Green L, Knigh M, Seeney F et al. 2016. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: A population based study. Br J Haematol. 172: 616– 624. https://doi.org/10.1111/bjh.13864

29. Shamshirsaz AA, Fox KA, Erfani H et al. 2017. Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time. Am J Obstet Gynecol. 216: 612.e1– 612.e5. https://doi.org/10.1016/j.ajog.2017.02.016

30. Bowman ZS, Manuck TA, Eller AG, Simon M, Silver RM. 2014. Risk factors for unscheduled delivery in patients with placenta accreta. Am J Obstet Gynecol. 210: 241.e1– 241.e6. https://doi.org/10.1016/j.ajog.2013.09.044

31. Rac MW, Wells CE, Twickler DM, Moschos E, McIntire DD, Dashe JS. 2015. Placenta accreta and vaginal bleeding according to gestational age at delivery. Obstet Gynecol. 125: 808– 813. https://doi.org/10.1097/AOG.0000000000000674

32. Robinson BK, Grobman WA. 2010. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 116: 835– 842. https://doi.org/10.1097/AOG.0b013e3181f3588d

33. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. 2017. FER-ASAP Investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: An international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 45: 443– 453. https://doi.org/10.1515/jpm-2016-0050

34. Wong L, Smith S, Gilstrop M et al. 2016. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 91: 590– 593. https://doi.org/10.1002/ajh.24361

35. Tam Tam KB, Dozier J, Martin JN. 2012. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: A systematic review. J Matern Fetal Neonatal Med. 25: 329– 334. https://doi.org/10.3109/14767058.2011.576720

36. Abbas F, Talati J, Wasti S, Akra S, Ghaffar S, Qureshi R. 2000. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol. 164: 1270– 1274. https://doi.org/10.1016/S0022-5347(05)67153-4

37. Matsubara S, Kuwata T, Usui R et al. 2013. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand. 92: 372– 377. https://doi.org/10.1111/aogs.12074

38. Belfort MA, Shamshirsaz AA, Fox KA. 2017. A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy. Am J Obstet Gynecol. 217: 222.e1– 222.e3. https://doi.org/10.1016/j.ajog.2017.05.001

39. Ioscovich A, Shatalin D, Butwick AJ, Ginosar Y, Orbach-Zinger S, Weiniger CF. 2016. Israeli survey of anesthesia practice related to placenta previa and accreta. Acta Anaesthesiol Scand. 60: 457– 464. https://doi.org/10.1111/aas.12656

40. Iwata A, Murayama Y, Itakura A, Baba K, Seki H, Takeda S. 2010. Limitations of internal iliac artery ligation for the reduction of intraoperative hemorrhage during cesarean hysterectomy in cases of placenta previa accreta. J Obstet Gynaecol Res. 36: 254– 259. https://doi.org/10.1111/j.1447-0756.2009.01157.x

41. Lilker, SJ, Meyer, RA, Downey, KN, Macarthur, AJ. Anesthetic considerations for placenta accreta. Int J Obstet Anesth. 2011; 20: 288– 292. https://doi.org/10.1016/j.ijoa.2011.06.001

42. Taylor NJ, Russell R. 2017. Anaesthesia for abnormally invasive placenta: A single-institution case series. Int J Obstet Anesth. 30: 10– 15. https://doi.org/10.1016/j.ijoa.2017.01.008

43. Munoz LA, Mendoza GJ, Gomez M, Reyes LE, Arevalo JJ. 2015. Anesthetic management of placenta accreta in a low-resource setting: A case series. Int J Obstet Anesth. 24: 329– 334. https://doi.org/10.1016/j.ijoa.2015.05.005

44. Kocaoglu N, Gunusen I, Karaman S, Ergenoglu AM, Firat V. 2012. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: A retrospective study. Ginekol Pol. 83: 99– 103.

45. Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. 2016. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: A retrospective cohort study of 50 consecutive cases. Can J Anaesth. 63: 1233– 1244. https://doi.org/10.1007/s12630-016-0695-x

46. Hong JY, Jee YS, Yoon HJ, Kim SM. 2003. Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: Maternal hemodynamics, blood loss and neonatal outcome. Int J Obstet Anesth. 12: 12– 16. https://doi.org/10.1016/S0959-289X(02)00183-8

47. Butwick AJ, Carvalho B, El-Sayed YY. 2014. Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth. 113: 661– 668. https://doi.org/10.1093/bja/aeu150

48. Walker MG, Pollard L, Talati C et al. 2016. Obstetric and anaesthesia checklists for the management of morbidly adherent placenta. J Obstet Gynaecol Can. 38: 1015– 1023. https://doi.org/10.1016/j.jogc.2016.08.015

49. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 389: 2105– 2116. 2017.

50. Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V. 2016. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: A systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 95: 28– 37. https://doi.org/10.1111/aogs.12798

51. Lakshmi SD, Abraham R. 2016. Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: A randomized controlled study. J Clin Diagn Res. 10: 17– 21. https://doi.org/10.7860/JCDR/2016/21702.9050

52. Ray I, Bhattacharya R, Chakraborty S, Bagchi C, Mukhopadhyay S. 2017. Role of Intravenous tranexamic acid on caesarean blood loss: A Prospective randomised study. J Obstet Gynaecol India.  66: 347– 352. https://doi.org/10.1007/s13224-016-0915-x

53. Maged AM, Helal OM, Elsherbin MM et al. 2015. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. Int J Gynecol Obstet. 131: 265– 268. https://doi.org/10.1016/j.ijgo.2015.05.027

54. Chou MM, Kung HF, Hwang JI, Chen WC, Tseng JJ. 2015. Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation. Taiwan J Obstet Gynecol. 54: 493– 498. https://doi.org/10.1016/j.tjog.2014.03.013

55. Luo F, Xie L, Xie P, Liu S, Zhu Y. 2017. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: A retrospective study. Taiwan J Obstet Gynecol. 56: 147– 152. https://doi.org/10.1016/j.tjog.2016.11.004

56. Takahashi H, Ohkuchi A, Usui R, Suzuki H, Baba Y, Matsubara S. 2016. Factors contributing to massive blood loss on peripartum hysterectomy for abnormally invasive placenta: Who bleeds more? Obstet Gynecol Int. 2016: 5349063. https://doi.org/10.1155/2016/5349063

57. Teixidor Vinas M, Chandraharan E, Moneta MV, Belli AM. 2014. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. Clin Radiol. 69: e345– e351. https://doi.org/10.1016/j.crad.2014.04.005

58. Ballas J, Hull AD, Saenz C et al. 2012. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: A management paradox. Am J Obstet Gynecol. 207: 216.e1– 216.e5. https://doi.org/10.1016/j.ajog.2012.06.007

59. Cali G, Forlani F, Giambanco L et al. 2014. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 179: 36– 41. https://doi.org/10.1016/j.ejogrb.2014.05.007

60. Carnevale FC, Kondo MM, Oliveira Sousa W et al. 2011. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol. 34: 758– 764. https://doi.org/10.1007/s00270-011-0166-2

61. D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura JR. 2015. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can Assoc Radiol. 66: 179– 184. https://doi.org/10.1016/j.carj.2014.08.002

62. Duan XH, Wang YL, Han XW et al. 2015. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol. 70: 932– 937. https://doi.org/10.1016/j.crad.2015.03.008

63. Kidney DD, Nguye AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. 2001. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. Am J Roentgenol.  176: 1521– 1524. https://doi.org/10.2214/ajr.176.6.1761521

64. Dubois J, Garel L, Grignon A, Lema M, Leduc L. 1997. Placenta percreta: Balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol. 176: 723– 726. https://doi.org/10.1016/S0002-9378(97)70582-9

65. Minas V, Gul N, Shaw E, Mwenenchanya S. 2015. Prophylactic balloon occlusion of the common iliac arteries for the management of suspected placenta accreta/percreta: Conclusions from a short case series. Arch Gynecol Obstet. 291: 461– 465. https://doi.org/10.1007/s00404-014-3436-9

66. Mok M, Heidemann B, Dundas K, Gillespie I, Clark V. 2008. Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth. 17: 255– 261. https://doi.org/10.1016/j.ijoa.2007.11.010

67. Panici PB, Anceschi M, Borgia ML et al. 2012. Intraoperative aorta balloon occlusion: Fertility preservation in patients with placenta previa accreta/increta. J Matern Fetal Neonatal Med. 25: 2512– 2516. https://doi.org/10.3109/14767058.2012.712566

68. Shih JC, Liu KL, Shyu MK. 2005. Temporary balloon occlusion of the common iliac artery: New approach to bleeding control during cesarean hysterectomy for placenta percreta. Am J Obstet Gynecol. 193: 1756– 1758. https://doi.org/10.1016/j.ajog.2005.08.033

69. Sivan E, Spira M, Achiron R et al. 2010. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: Can it prevent cesarean hysterectomy? Am J Perinatol. 27: 455– 461. https://doi.org/10.1055/s-0030-1247599

70. Tan CH, Tay KH, Sheah K et al. 2007. erioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. Am J Roentgenol. 189: 1158– 1163. https://doi.org/10.2214/AJR.07.2417

71. Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. 2015. Precesarean prophylactic balloon catheters for suspected placenta accreta: A randomized controlled trial. Obstet Gynecol.  126: 1022– 1028. https://doi.org/10.1097/AOG.0000000000001113

72. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W. 2006. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol.  29: 354– 361. https://doi.org/10.1007/s00270-005-0023-2

73. Shrivastava V, Nageotte M, Majo C, Haydo M, Wing D. 2007. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol. 197: 402.e1– 402.e5. https://doi.org/10.1016/j.ajog.2007.08.001

74. Levine AB, Kuhlman K, Bonn J. 1999. Placenta accreta: Comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med. 8: 173– 176. https://doi.org/10.1002/(SICI)1520-6661(199907/08)8:4<173::AID-MFM7>3.3.CO;2-M

75. Clausen C, Stensballe J, Albrechtse CK, Hanse MA, Lonn L, Langhoff-Roos J. 2013. Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta. Acta Obstet Gynecol Scan. 92: 386– 391. https://doi.org/10.1111/j.1600-0412.2012.01451.x

76. Sentilhes L, Goffinet F, Kayem G. 2013. Management of placenta accreta. Acta Obstet Gynecol Scand. 92: 1125– 1134. https://doi.org/10.1111/aogs.12222

77. Greenberg JI, Suliman A, Iranpou P, Angle N. 2007. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: A cautionary case. Am J Obstet Gynecol. 197: 470.e1– 470.e4. https://doi.org/10.1016/j.ajog.2007.05.017

78. Sewell MF, Rosenblum D, Ehrenberg H. 2006. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol. 108: 746– 748. https://doi.org/10.1097/01.AOG.0000201992.80130.2c

79. Teare J, Evans E, Belli A, Wendler R. 2014. Sciatic nerve ischaemia after iliac artery occlusion balloon catheter placement for placenta percreta. Int J Obstet Anesth. 23: 178– 181. https://doi.org/10.1016/j.ijoa.2013.11.002

80. Chouliaras S, Hickling DJ, Tuck JS. 2009. Thromboembolism of the leg following prophylactic balloon occlusion of the uterine arteries. BJOG. 116: 1278– 1279. https://doi.org/10.1111/j.1471-0528.2009.02217.x

81. Gagnon J, Boucher L, Kaufman I, Brown R, Moore A. 2013. Iliac artery rupture related to balloon insertion for placenta accreta causing maternal hemorrhage and neonatal compromise. Can J Anaesth. 60: 1212– 1217. https://doi.org/10.1007/s12630-013-0038-0

82. Bishop S, Butler K, Monaghan S, Chan K, Murphy G, Edozie L. 2011. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 20: 70– 73. https://doi.org/10.1016/j.ijoa.2010.09.012

83. Matsueda S, Hidaka N, Kondo Y, Fujiwara A, Fukushima K, Kato K. 2015. External iliac artery thrombosis after common iliac artery balloon occlusion during cesarean hysterectomy for placenta accreta in cervico-isthmic pregnancy. J Obstet Gynaecol Res. 41: 1826– 1830. https://doi.org/10.1111/jog.12777

84. Dilauro MD, Dason S, Athreya S. 2012. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: Literature review and analysis. Clin Radiol. 67: 515– 520. https://doi.org/10.1016/j.crad.2011.10.031

85. Neb H, Zacharowski K, Meybohm P. 2017. Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol. 30: 294– 299. https://doi.org/10.1097/ACO.0000000000000463

86. McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ. 2010. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care. 38: 492– 499. https://doi.org/10.1177/0310057X1003800313

87. Elagamy A, Abdelaziz A, Ellaithy M. 2013. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth. 22: 289– 293. https://doi.org/10.1016/j.ijoa.2013.05.007

88. Lew E, Tagore S. 2015. Implementation of an obstetric cell salvage service in a tertiary women’s hospital. Singapore Med J. 56: 445– 449. https://doi.org/10.11622/smedj.2015121

89. Albright CM, Rouse DJ, Werner EF. 2014. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol. 124: 690– 696. https://doi.org/10.1097/AOG.0000000000000465

90. Esper SA, Waters JH. 2011. Intra-operative cell salvage: A fresh look at the indications and contraindications. Blood Transfus. 9: 139– 147.

91. Weiniger CF, Kabiri D, Ginosar Y, Ezra Y, Shachar B, Lyell DJ. 2016. Suspected placenta accreta and cesarean hysterectomy: Observational cohort utilizing an intraoperative decision strategy. Eur J Obstet Gynecol Reprod Biol. 198: 56– 61. https://doi.org/10.1016/j.ejogrb.2015.12.020

92. Belfort MA, Shamshiraz AA, Fox K. 2017. Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. Am J Obstet Gynecol. 216: 78.e1– 78.e2. https://doi.org/10.1016/j.ajog.2016.10.030

93. Rossetti D, Vitale SG, Bogani G, Rapisarda AM, Gulino FA, Frigerio L. 2015. Usefulness of vessel-sealing devices for peripartum hysterectomy: A retrospective cohort study. Updates Surg. 67: 301– 304. https://doi.org/10.1007/s13304-015-0289-0

94. Arendas K, Lortie KJ, Singh SS. 2012. Delayed laparoscopic management of placenta increta. J Obstet Gynaecol Can. 34: 186– 189. https://doi.org/10.1016/S1701-2163(16)35162-3

95. Smith DD, Perez-Delboy A, Burke WM, Tergas AI. 2016. Buttock necrosis after uterine artery embolization for delayed hysterectomy in placenta percreta. Case Rep Obstet Gynecol. 2016: 6921280. https://doi.org/10.1155/2016/6921280

96. Rupley DM, Tergas AI, Palmerola KL, Burke WM. 2016. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecol Oncol Rep. 17: 53– 55. https://doi.org/10.1016/j.gore.2016.05.009

97. Skinner BD, Golichowski AM, Raff GJ. 2012. Laparoscopic-assisted vaginal hysterectomy in a patient with placenta percreta. JSLS. 16: 143– 147. https://doi.org/10.4293/108680812X13291597717022